Senior insider sale
SUPERNUS PHARMACEUTICALS, INC. — senior position signals high conviction
$1.47M
31K shares
What this filing means
NEWHALL CHARLES W III plans to sell 31K shares of SUPERNUS PHARMACEUTICALS, INC. valued at approximately $1.47M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/9/2025ACC: 0001950047-25-007867
Director
Since Feb 2026
31K
Shares to sell
$1.47M
Approx. market value
25K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
In-Kind Distribution
N/A
5/1/2012
25KTotal acquired25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/1/2012 | In-Kind Distribution N/A | 25K | — |
| Total | 25K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
3.59K
Market value
$161.5K
8/27/2025
—Completed
Units to sell
1K
Market value
$45.0K
8/25/2025
—Completed
Units to sell
1.41K
Market value
$63.5K
8/22/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
25K
Market value
$1.20M
10/9/2025
Total
Units
31K
Value
$1.47M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/27/2025 | 3.59K | $161.5K | — | Completed |
8/25/2025 | 1K | $45.0K | — | Completed |
8/22/2025 | 1.41K | $63.5K | — | Completed |
| Planned — Approximate Date | ||||
10/9/2025 | 25K | $1.20M | NASDAQ | Planned |
| Total | 31K | $1.47M | ||